Infusion pumps are classified depending on the mode of their operation. For instance, in a syringe pump, fluid is held in the syringe reservoir and the fluid delivery is controlled by a moveable piston, whereas in an elastomeric pump, a stretchable balloon reservoir contains fluid and its flow rate is controlled by the pressure from elastic walls of the balloon. Such product diversity, driven by the nature of its intended use, is expected to have a positive impact on global programmable infusion pumps and catheters market growth over the forecast period.
Advantages offered by programmable infusion pumps over non-programmable infusion pumps is expected to drive the global programmable infusion pumps and catheters market growth during the forecast period. For instance, the use of non-programmable infusion pumps for intravenous infusion is associated with problems such as uncontrolled dosing, possibility of missing dosage of medication, and others. For instance, according to National Center for Biotechnology Information (NCBI), in a study conducted on intravenous medication administration errors (MAEs) in Ethiopia, from March 2015 to April 2015, out of 134 cases the rate of MAE was reported to be 46%, with missed dosage being the most common error. However, high costs of programmable infusion pumps is expected to restrain global programmable infusion pumps market growth up to certain extent.
- This report provides in-depth analysis of global programmable infusion pumps and catheters market, and provides market size (USD Mn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026–2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and presents an attractive investment proposition matrix for this market
- This study also provides key insights into market drivers, restraints, opportunities, new product launches or approvals, regional outlooks, and competitive strategies adopted by leading players
- It profiles leading players in the global programmable infusion pumps and catheters market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key companies covered as a part of this study include ICU Medical, Inc., Smiths Group plc., Baxter International Inc., Fresenius Se & Co. KGaA, Johnson & Johnson, Medtronic PLC, Becton, Dickinson and Company, Terumo Corporation, B. Braun Melsungen AG, and Moog Inc.
- Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launches, by technology up-gradation, market expansion, and marketing tactics
- The global programmable infusion pumps and catheters market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global programmable infusion pumps and catheters market
-
- Volumetric Pumps
- Syringe Pumps
- Enteral Pumps
- Insulin Pumps
- Implantable Pumps
- Patient Controlled Analgesia Pumps
- Pump Accessories
-
-
- Oncology
- Pediatrics/Neonatology
- Pain
- Gastroenterology
- Hematology
- Diabetes
-
- Single Channel
- Multi-channel
-
- Hospitals
- Ambulatory Clinics
- Homecare
- Clinics
- Others
-
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
-
- ICU Medical, Inc.
- Smith’s Group plc.
- Baxter International Inc.
- Fresenius Se & Co. KGaA
- Johnson & Johnson
- Medtronic plc.
- Becton
- Dickinson and Company
- Terumo Corporation
- Braun Melsungen AG
- Moog Inc.
